Long-acting penicillin frequently rushes across the country

Long-acting penicillin is a powdered preparation and is currently recognized as a specific drug for preventing streptococcal infection, reducing recurrence of rheumatic fever, and rheumatic heart valve disease. According to Sun Zhongshi, a national expert on the rational drug use monitoring network of the Health and Family Planning Commission, long-acting penicillin injection is a long-acting drug that is commonly used, cheap, and clinically indispensable. It has been used since the 1950s.

According to the database of the State Food and Drug Administration, only four pharmaceutical companies, namely Ruiyang Pharmaceutical Co., Ltd., Shijiazhuang Zhongnuo Pharmaceutical Shijiazhuang Co., Ltd., Jiangxi Dongfeng Pharmaceutical Co., Ltd. and North China Pharmaceutical Co., Ltd., have production qualifications. . However, two of them have ceased production and only two are in production. A manager of Jiangxi Dongfeng Pharmaceutical Co., Ltd. said in an interview with the media that medicines are in short supply and the company has stopped production for one year. Since the GMP certificate for long-acting penicillin injection for Jiangxi Dongfeng Company has expired and the drug has been discontinued, it is expected that it will take several months to get the new certificate. Ruiyang Pharmaceutical sales personnel also publicly stated that they have not produced such drugs.

Sun Zhongshi stated that many small businesses are reluctant to produce low-priced drugs at a loss, and that big companies are even harder in the competitive bidding model with low prices. “In order not to lose market share, we can only win bids by doing everything possible, and the prices of many antibiotics are Below the cost price."

Why cheap medicines make trouble

In recent years, not only long-acting penicillins but also basic drugs, such as cedilan, erythromycin for injection, protamine and dipyridamole, have been gradually disappearing in the market for decades.

Why are cheap lifesaving drugs hard to find in the market? Sun Zhongshi said that the main reason is "unprofitable." Long-acting penicillin is a powdered preparation and is currently recognized as a specific drug for preventing streptococcal infection, reducing recurrence of rheumatic fever, and rheumatic heart valve disease. According to Sun Zhongshi, a national expert on the rational drug use monitoring network of the Health and Family Planning Commission, long-acting penicillin injection is a long-acting drug that is commonly used, cheap, and clinically indispensable. It has been used since the 1950s.

According to the database of the State Food and Drug Administration, only four pharmaceutical companies, namely Ruiyang Pharmaceutical Co., Ltd., Shijiazhuang Zhongnuo Pharmaceutical Shijiazhuang Co., Ltd., Jiangxi Dongfeng Pharmaceutical Co., Ltd. and North China Pharmaceutical Co., Ltd., have production qualifications. . However, two of them have ceased production and only two are in production. A manager of Jiangxi Dongfeng Pharmaceutical Co., Ltd. said in an interview with the media that medicines are in short supply and the company has stopped production for one year. Since the GMP certificate for long-acting penicillin injection for Jiangxi Dongfeng Company has expired and the drug has been discontinued, it is expected that it will take several months to get the new certificate. Ruiyang Pharmaceutical sales personnel also publicly stated that they have not produced such drugs.

Sun Zhongshi stated that many small businesses are reluctant to produce low-priced drugs at a loss, and that big companies are even harder in the competitive bidding model with low prices. “In order not to lose market share, we can only win bids by doing everything possible, and the prices of many antibiotics are Below the cost price."

Why cheap medicines make trouble

In recent years, not only long-acting penicillins but also basic drugs, such as cedilan, erythromycin for injection, protamine and dipyridamole, have been gradually disappearing in the market for decades.

Why are cheap lifesaving drugs hard to find in the market? Sun Zhongshi said that the main reason is "unprofitable." "The terminal's low price does not allow profit to be paid to intermediate circulation. It is difficult for hospital doctors and sales personnel to profit from it, and their enthusiasm is reduced. This results in the entry of low-priced drugs into the market and the decline in purchase volume. As a result, producers have to reduce their production, making it difficult to save money. seek."

Zhang Zheng, a pharmacist in Chaoyang Hospital, told reporters that one of the major reasons for the low price of drugs for patients is related to the current medical system. “Now many hospitals use drugs to provide medicine, and some doctors are unwilling to open low-priced drugs, and there is no market demand, and pharmaceutical companies are naturally unwilling to produce. In addition, doctors who use cheap drugs have lower rebates and are more inclined to use them. The reasons for the expensive drugs.” “The terminal price is low and it is not possible to profit from the middle distribution chain. It is difficult for hospital doctors and sales staff to profit from it, and the enthusiasm is reduced, resulting in the entry of low-priced drugs into the market and the decrease in purchase volume, resulting in manufacturers having to Reducing production will make it difficult for cheap life-saving medicines."

Zhang Zheng, a pharmacist in Chaoyang Hospital, told reporters that one of the major reasons for the low price of drugs for patients is related to the current medical system. “Now many hospitals use drugs to provide medicine, and some doctors are unwilling to open low-priced drugs, and there is no market demand, and pharmaceutical companies are naturally unwilling to produce. In addition, doctors who use cheap drugs have lower rebates and are more inclined to use them. Reasons for expensive drugs."